stella
beta
Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation — Stella
Recruiting
Back to Recurrent Renal Cell Carcinoma trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
Trial locations
(1 site)
United States
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania
View full record on ClinicalTrials.gov